$CERS
CERUS CORP

2018 Q4 Form 10-Q Financial Statement

#000156459018026282 Filed on November 01, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $20.24M $19.33M $10.80M
YoY Change 24.63% 79.03% 6.11%
Cost Of Revenue $8.440M $8.140M $5.350M
YoY Change -7.56% 52.15% -1.83%
Gross Profit $11.80M $11.19M $5.449M
YoY Change 24.34% 105.36% 15.35%
Gross Profit Margin 58.3% 57.89% 50.47%
Selling, General & Admin $14.83M $13.96M $12.18M
YoY Change 18.55% 14.61% 0.16%
% of Gross Profit 125.68% 124.75% 223.53%
Research & Development $12.42M $10.83M $7.886M
YoY Change 59.64% 37.33% 12.13%
% of Gross Profit 105.25% 96.78% 144.72%
Depreciation & Amortization $340.0K $320.0K $460.0K
YoY Change -24.44% -30.43% 6.98%
% of Gross Profit 2.88% 2.86% 8.44%
Operating Expenses $27.26M $24.79M $20.12M
YoY Change 34.02% 23.24% 4.53%
Operating Profit -$15.46M -$13.60M -$12.38M
YoY Change 42.49% 9.84% -13.16%
Interest Expense -$1.150M -$1.050M $1.090M
YoY Change 35.29% -196.33% 86.01%
% of Operating Profit
Other Income/Expense, Net $460.0K $510.0K -$986.0K
YoY Change 228.57% -151.72% 84.99%
Pretax Income -$16.15M -$14.14M -$13.37M
YoY Change 39.71% 5.77% -9.63%
Income Tax $60.00K $60.00K $50.00K
% Of Pretax Income
Net Earnings -$16.21M -$14.19M -$13.42M
YoY Change 41.08% 5.77% -6.66%
Net Earnings / Revenue -80.06% -73.42% -124.28%
Basic Earnings Per Share -$0.12 -$0.11 -$0.12
Diluted Earnings Per Share -$0.12 -$0.11 -$0.12
COMMON SHARES
Basic Shares Outstanding 135.7M 109.8M
Diluted Shares Outstanding 109.8M

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $117.6M $119.0M $59.60M
YoY Change 93.71% 99.66% -26.6%
Cash & Equivalents $28.86M $22.33M $17.24M
Short-Term Investments $88.72M $96.67M $42.60M
Other Short-Term Assets $7.000M $7.400M $4.100M
YoY Change 200.43% 80.49% -43.06%
Inventory $13.54M $13.30M $14.30M
Prepaid Expenses
Receivables $8.752M $10.50M $10.50M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $146.9M $150.2M $88.40M
YoY Change 63.41% 69.91% -18.15%
LONG-TERM ASSETS
Property, Plant & Equipment $8.130M $3.100M $2.300M
YoY Change 283.67% 34.78% -28.13%
Goodwill $1.316M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.050M $6.700M $4.400M
YoY Change -1.89% 52.27% 57.14%
Total Long-Term Assets $16.56M $11.50M $8.700M
YoY Change 98.39% 32.18% 7.41%
TOTAL ASSETS
Total Short-Term Assets $146.9M $150.2M $88.40M
Total Long-Term Assets $16.56M $11.50M $8.700M
Total Assets $163.5M $161.7M $97.10M
YoY Change 66.38% 66.53% -16.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.60M $13.00M $12.50M
YoY Change 69.45% 4.0% 81.16%
Accrued Expenses $19.80M $18.10M $10.70M
YoY Change 69.06% 69.16% 4.9%
Deferred Revenue $498.0K
YoY Change 11.91%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $7.900M $5.700M $0.00
YoY Change -100.0%
Total Short-Term Liabilities $52.68M $43.20M $23.90M
YoY Change 127.74% 80.75% 4.37%
LONG-TERM LIABILITIES
Long-Term Debt $22.00M $24.10M $29.80M
YoY Change -26.17% -19.13% 106.94%
Other Long-Term Liabilities $4.250M $2.500M $6.300M
YoY Change 597.87% -60.32% -1.56%
Total Long-Term Liabilities $4.250M $26.60M $36.10M
YoY Change 597.87% -26.32% 73.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $52.68M $43.20M $23.90M
Total Long-Term Liabilities $4.250M $26.60M $36.10M
Total Liabilities $78.94M $69.90M $59.90M
YoY Change 33.11% 16.69% 36.76%
SHAREHOLDERS EQUITY
Retained Earnings -$778.9M -$709.8M
YoY Change 7.98%
Common Stock $863.7M $747.0M
YoY Change 13.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $84.52M $91.80M $37.18M
YoY Change
Total Liabilities & Shareholders Equity $163.5M $161.7M $97.09M
YoY Change 66.38% 66.55% -16.38%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$16.21M -$14.19M -$13.42M
YoY Change 41.08% 5.77% -6.66%
Depreciation, Depletion And Amortization $340.0K $320.0K $460.0K
YoY Change -24.44% -30.43% 6.98%
Cash From Operating Activities -$7.100M -$4.890M -$12.85M
YoY Change -29.28% -61.95% -20.92%
INVESTING ACTIVITIES
Capital Expenditures -$520.0K -$470.0K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $7.750M $1.010M -$12.34M
YoY Change -268.11% -108.18% -196.71%
Cash From Investing Activities $7.230M $530.0K -$12.33M
YoY Change -256.83% -104.3% -198.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.400M 12.39M 21.90M
YoY Change -43.51% -43.42% 146.62%
NET CHANGE
Cash From Operating Activities -7.100M -4.890M -12.85M
Cash From Investing Activities 7.230M 530.0K -12.33M
Cash From Financing Activities 6.400M 12.39M 21.90M
Net Change In Cash 6.530M 8.030M -3.280M
YoY Change -296.69% -344.82% -163.69%
FREE CASH FLOW
Cash From Operating Activities -$7.100M -$4.890M -$12.85M
Capital Expenditures -$520.0K -$470.0K $0.00
Free Cash Flow -$6.580M -$4.420M -$12.85M
YoY Change -34.46% -65.6% -19.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
47013000
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
135689199
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13683000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22327000
CY2018Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
96669000
CY2018Q3 cers Accrual For Manufacturing And Development Payment Liability Current
AccrualForManufacturingAndDevelopmentPaymentLiabilityCurrent
5858000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23192000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13402000
cers Non Cash Tax Expense Benefit From Other Realized Gain Loss On Available For Sale Securities
NonCashTaxExpenseBenefitFromOtherRealizedGainLossOnAvailableForSaleSecurities
3825000
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
3466000
cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
21191000
cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
13926000
us-gaap Profit Loss
ProfitLoss
-49099000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42200000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5029000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
30000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
99000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
86352000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31668000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11126000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5503000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25056000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17241000
CY2017Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
28031000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
12032000
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
75361000
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
The Company invoices its customers based upon the payment terms in the contracts, which is generally from 30 to 60 days.
CY2018Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2017Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000
us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
CY2018Q3 us-gaap Restricted Cash
RestrictedCash
2500000
CY2018Q3 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
2
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
38781000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, including those related to the nature and timing of satisfaction of performance obligations, the timing when the customer obtains control of products or services, the standalone selling price (&#8220;SSP&#8221;) of performance obligations, variable consideration, accounts receivable, inventory reserves, fair values of investments, stock-based compensation, intangible assets and goodwill, useful lives of intangible assets and property and equipment, income taxes, and accrued liabilities, among others. The Company bases its estimates on historical experience, future projections, and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, available-for-sale securities and accounts receivable.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the Company&#8217;s investment policy, substantially all of the Company&#8217;s cash, cash equivalents and available-for-sale securities are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company&#8217;s investments carry high credit quality ratings, which is in accordance with its investment policy. At September&#160;30, 2018, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company&#8217;s cash equivalents and short-term investments.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its unaudited condensed consolidated balance sheets and records a charge on its unaudited condensed consolidated statements of operations as a component of selling, general and administrative expenses.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had two and three customers that accounted for more than 10% of the Company&#8217;s outstanding trade receivables at September&#160;30, 2018 and December&#160;31, 2017, respectively. These customers cumulatively represented approximately 61% and 53% of the Company&#8217;s outstanding trade receivables at September&#160;30, 2018 and December&#160;31, 2017, respectively. To date, the Company has not experienced collection difficulties from these customers.</p></div>
CY2017Q4 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
3
cers Work In Process Inventory Life Period
WorkInProcessInventoryLifePeriod
P1Y
CY2018Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
300000
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
800000
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1600000
CY2018Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
103586000
CY2018Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
326000
CY2018Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
103260000
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
50868000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
97000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
50771000
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
75555000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
38836000
us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Guarantee and Indemnification Arrangements</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company&#8217;s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company&#8217;s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable. The Company has not experienced significant or systemic warranty claims nor is it aware of any existing current warranty claims. Accordingly, the Company had not accrued for any future warranty costs for its products at September&#160;30, 2018 and December&#160;31, 2017.</p></div>
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1500000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P10Y
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2018Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19874000
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18942000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20004000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18646000
cers Product Warranty Term
ProductWarrantyTerm
P1Y
CY2018Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44383000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27328000
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
27899000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
11990000
CY2018Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
90648000
CY2017Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
44514000
CY2018Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
314000
CY2017Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
97000
CY2018Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
4990000
CY2018Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
12000
CY2018Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
95638000
CY2017Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
44514000
CY2018Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
326000
CY2017Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
97000
CY2018Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3685000
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4299000
CY2018Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9637000
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10158000
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8509000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7372000
CY2018Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3806000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1811000
CY2018Q3 cers Accrued Development Costs Current
AccruedDevelopmentCostsCurrent
1293000
CY2017Q4 cers Accrued Development Costs Current
AccruedDevelopmentCostsCurrent
794000
CY2018Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3156000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1735000
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
7857000
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
8571000
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8572000
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
5000000
CY2018Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2018Q3 cers Longterm Debt Maturities Repayments Of Interest In Next Twelve Months
LongtermDebtMaturitiesRepaymentsOfInterestInNextTwelveMonths
689000
CY2018Q3 cers Long Term Debt Maturities Repayments Of Interest In Year Two
LongTermDebtMaturitiesRepaymentsOfInterestInYearTwo
2470000
CY2018Q3 cers Long Term Debt Maturities Repayments Of Interest In Year Three
LongTermDebtMaturitiesRepaymentsOfInterestInYearThree
1689000
CY2018Q3 cers Long Term Debt Maturities Repayments Of Interest In Year Four
LongTermDebtMaturitiesRepaymentsOfInterestInYearFour
891000
CY2018Q3 cers Long Term Debt Maturities Repayments Of Interest In Year Five
LongTermDebtMaturitiesRepaymentsOfInterestInYearFive
2554000
CY2018Q3 cers Long Term Debt Maturities Repayments Of Interest
LongTermDebtMaturitiesRepaymentsOfInterest
8293000
CY2018Q3 cers Long Term Debt Maturities Repayments Of Principal And Interest In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInNextTwelveMonths
689000
CY2018Q3 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearTwo
10327000
CY2018Q3 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearThree
10260000
CY2018Q3 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFour
9463000
CY2018Q3 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFive
7554000
CY2018Q3 cers Long Term Debt Maturities Repayments Of Principal And Interest
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterest
38293000
cers Minimum Term Of Non Cancelable Operating Leases
MinimumTermOfNonCancelableOperatingLeases
P1Y
cers Expiration Of Non Cancelable Operating Leases Maximum Year
ExpirationOfNonCancelableOperatingLeasesMaximumYear
2029
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
545000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3306000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2362000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2209000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2234000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
16860000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
27516000
CY2010 cers Proceeds From Landlord Financing Leasehold Improvement
ProceedsFromLandlordFinancingLeaseholdImprovement
1100000
CY2018Q3 cers Accrued Leasehold Improvements Current And Accrued Leasehold Improvements Noncurrent
AccruedLeaseholdImprovementsCurrentAndAccruedLeaseholdImprovementsNoncurrent
200000
CY2018Q3 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
5600000
CY2017Q3 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
3000000
cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
15700000
cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
9400000
CY2018Q3 cers Accrual For Manufacturing Of Entity Products
AccrualForManufacturingOfEntityProducts
6198000
CY2017Q4 cers Accrual For Manufacturing Of Entity Products
AccrualForManufacturingOfEntityProducts
4687000
CY2018Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
1714000
CY2017Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
231000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001564590-18-026282-index-headers.html Edgar Link pending
0001564590-18-026282-index.html Edgar Link pending
0001564590-18-026282.txt Edgar Link pending
0001564590-18-026282-xbrl.zip Edgar Link pending
cers-10q_20180930.htm Edgar Link pending
cers-20180930.xml Edgar Link completed
cers-20180930.xsd Edgar Link pending
cers-20180930_cal.xml Edgar Link unprocessable
cers-20180930_def.xml Edgar Link unprocessable
cers-20180930_lab.xml Edgar Link unprocessable
cers-20180930_pre.xml Edgar Link unprocessable
cers-ex101_221.htm Edgar Link pending
cers-ex102_222.htm Edgar Link pending
cers-ex103_201.htm Edgar Link pending
cers-ex311_6.htm Edgar Link pending
cers-ex312_11.htm Edgar Link pending
cers-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gb3yfmdty4gv000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending